Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 13 01:10PM ET
1.66
Dollar change
-0.05
Percentage change
-2.92
%
Index- P/E- EPS (ttm)-0.40 Insider Own37.84% Shs Outstand38.93M Perf Week-2.35%
Market Cap66.90M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float25.05M Perf Month-10.27%
Income-15.57M PEG- EPS next Q- Inst Own1.48% Short Float8.40% Perf Quarter-23.85%
Sales1.88M P/S35.58 EPS this Y- Inst Trans-20.96% Short Ratio85.37 Perf Half Y-37.12%
Book/sh-0.75 P/B- EPS next Y- ROA-57.90% Short Interest2.10M Perf Year74.74%
Cash/sh0.36 P/C4.66 EPS next 5Y- ROE- 52W Range0.78 - 4.00 Perf YTD84.44%
Dividend Est.- P/FCF- EPS past 5Y25.94% ROI- 52W High-58.50% Beta0.24
Dividend TTM- Quick Ratio1.82 Sales past 5Y136.03% Gross Margin- 52W Low113.45% ATR (14)0.19
Dividend Ex-Date- Current Ratio1.82 EPS Y/Y TTM75.77% Oper. Margin-908.96% RSI (14)41.31 Volatility10.82% 11.84%
Employees35 Debt/Eq- Sales Y/Y TTM- Profit Margin-829.85% Recom2.00 Target Price1.25
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q52.99% Payout- Rel Volume6.97 Prev Close1.71
Sales Surprise- EPS Surprise- Sales Q/Q87.78% Earnings- Avg Volume24.64K Price1.66
SMA20-3.90% SMA50-17.65% SMA200-27.28% Trades Volume103,151 Change-2.92%
Date Action Analyst Rating Change Price Target Change
Dec-02-21Downgrade Jefferies Buy → Hold $38 → $5
Dec-02-21Downgrade BofA Securities Buy → Underperform $45 → $5
Dec-01-21Downgrade William Blair Outperform → Mkt Perform
Dec-01-21Downgrade H.C. Wainwright Buy → Neutral
Sep-09-21Initiated Robert W. Baird Outperform $50
Aug-04-21Upgrade H.C. Wainwright Neutral → Buy $100
Apr-05-21Downgrade H.C. Wainwright Buy → Neutral
Jan-11-21Initiated BofA Securities Buy $25
Dec-29-20Initiated Evercore ISI Outperform $30
Feb-07-20Initiated Jefferies Buy $25
Nov-11-24 08:00AM
Sep-16-24 07:00AM
07:00AM
Sep-10-24 07:00AM
Sep-03-24 07:00AM
07:00AM Loading…
Aug-06-24 07:00AM
May-21-24 07:49AM
May-16-24 08:00AM
May-03-24 07:00AM
Apr-29-24 05:30PM
05:30PM
Mar-25-24 07:00AM
Feb-26-24 08:00AM
Jan-10-24 03:00PM
Dec-18-23 04:30PM
07:00AM Loading…
Nov-07-23 07:00AM
Oct-31-23 08:00AM
Oct-30-23 08:00AM
Oct-26-23 08:30AM
Oct-23-23 07:45AM
Oct-04-23 03:55PM
Sep-27-23 10:00AM
Sep-07-23 08:00AM
Jun-20-23 08:00AM
Jun-07-23 08:00AM
May-22-23 07:44AM
May-18-23 08:30AM
Apr-18-23 04:30PM
04:30PM
Mar-02-23 05:41AM
08:00AM Loading…
Mar-01-23 08:00AM
Jan-09-23 04:30PM
Dec-20-22 10:43AM
Dec-13-22 02:57PM
08:00AM
Nov-23-22 04:30PM
Sep-13-22 09:57AM
07:00AM
Aug-29-22 11:33AM
07:00AM
Jun-27-22 11:01AM
Jun-06-22 05:25PM
Jun-01-22 07:55AM
May-27-22 07:00AM
May-23-22 10:15AM
May-17-22 08:45AM
Apr-28-22 07:00AM
Apr-14-22 01:30PM
09:04AM
07:00AM
Apr-08-22 08:00AM
Jan-12-22 05:43AM
Jan-11-22 04:05PM
Dec-30-21 09:15AM
08:00AM
Dec-28-21 10:15AM
Dec-15-21 10:23AM
07:00AM
Dec-14-21 07:50PM
Dec-13-21 12:06PM
Dec-10-21 08:00AM
Dec-06-21 07:56PM
Dec-03-21 03:04AM
Dec-02-21 02:47PM
10:25AM
Dec-01-21 04:45PM
01:39PM
11:45AM
08:36AM
08:00AM
Nov-24-21 08:00AM
Nov-12-21 08:00AM
Nov-10-21 07:00AM
Oct-22-21 06:13AM
Oct-21-21 07:00AM
Oct-20-21 07:00AM
Oct-15-21 06:50AM
Sep-20-21 02:33PM
12:09PM
12:05PM
07:30AM
Sep-16-21 11:50AM
07:00AM
Sep-10-21 02:00PM
08:25AM
07:00AM
Sep-09-21 07:00AM
Sep-08-21 05:54PM
Sep-07-21 08:00AM
Aug-31-21 07:00AM
Aug-27-21 12:57PM
09:50AM
Aug-26-21 04:14PM
09:20AM
07:00AM
Aug-12-21 11:05AM
Aug-10-21 08:00AM
05:19AM
Aug-04-21 04:39PM
04:14PM
BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ.